Cargando…
Inhibition of Lysyl Oxidases Improves Drug Diffusion and Increases Efficacy of Cytotoxic Treatment in 3D Tumor Models
Tumors are characterized by a rigid, highly cross-linked extracellular matrix (ECM), which impedes homogeneous drug distribution and potentially protects malignant cells from exposure to therapeutics. Lysyl oxidases are major contributors to tissue stiffness and the elevated expression of these enzy...
Autores principales: | Schütze, Friedrich, Röhrig, Florian, Vorlová, Sandra, Gätzner, Sabine, Kuhn, Anja, Ergün, Süleyman, Henke, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665164/ https://www.ncbi.nlm.nih.gov/pubmed/26620400 http://dx.doi.org/10.1038/srep17576 |
Ejemplares similares
-
LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy
por: Rossow, Leonie, et al.
Publicado: (2018) -
The Interactome of Cancer-Related Lysyl Oxidase and Lysyl Oxidase-Like Proteins
por: Vallet, Sylvain D., et al.
Publicado: (2020) -
Multifunctional Lysyl Oxidases
por: Trackman, Philip C.
Publicado: (2023) -
VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors
por: Röhrig, F, et al.
Publicado: (2017) -
Origin and evolution of lysyl oxidases
por: Grau-Bové, Xavier, et al.
Publicado: (2015)